Augmedix Raises Additional $19M in Series B Funding

augmedixAugmedix, a San Francisco, CA-based medical documentation company, raised $19m in Series B funding.

Backers included Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments and others.

The company intends to use the funds to accelerate product development, including automation capabilities, and to strategically scale its technology-enabled service across health systems and private clinics nationwide.

Led by Manny Krakaris, chief executive officer, Augmedix turns natural clinician-patient conversation into medical documentation, in real-time, so that clinicians can focus on patient care. The platform is powered by a combination of proprietary natural-language-processing technology and medical documentation expert teams to provide clinicians with hardware, Smartphones or Google Glass, to securely stream the clinic visit to its cloud-based platform. Tech-enabled remote specialists utilize proprietary automation modules to generate medical documentation that is comprehensive and timely delivered.
The service works with over 25 specialties and supports most EHRs.
Fifteen national health systems, including Sutter Health, CommonSpirit Health, and US Oncology, representing more than 10% of clinicians in the United States, have partnered with Augmedix.



Join the discussion